MMP-13 inhibitors (Wyeth)

N/A

Report date: 2025/02/01 20:00:06
NME

Base Information

Drug NameMMP-13 inhibitors (Wyeth)
Drug Alias Namematrix metalloprotease inhibitors (American Cyanamid)MMP inhibitors (American Cyanamid)matrix metalloprotease inhibitors (Wyeth)WAY-170523
ClassificationSmall molecules > Heterocyclic drugs
Mechanisms of ActionMatrix metalloproteinase 13 inhibitors
TargetsMatrix metalloproteinase 13
Therapy Area/IndicationsAtherosclerosisOsteoarthritisArthritis, Rheumatoid +[4] 
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryUnited States
CombinationsNo
Global Highest StatusPending (Preclinical)
Highest Status in ChinaN/A
Originator CompaniesAmerican Cyanamid
China Registration ClassN/A

Develop Information

Active CompaniesN/A
Inactive CompaniesWyeth LlcAmerican Cyanamid
Active IndicationsN/A
Inactive IndicationsAtherosclerosisOsteoarthritisArthritis, Rheumatoid +[4] 

Other Information

ATC CodeN/A
Related LinksN/A